ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Ann Thorac Surg 1995;60:1382-1389
© 1995 The Society of Thoracic Surgeons


Original Articles: General Thoracic

Investigation for Mediastinal Disease in Patients With Apparently Operable Lung Cancer

The Canadian Lung Oncology Group*

McMaster University, Hamilton; The University of Toronto, Toronto; Laval University, Sainte-Foy; the University of Western Ontario, London; the University of Ottawa, Ottawa; and Hotel Dieu, Windsor Western Hospital Centre, Windsor, Canada

Accepted for publication June 24, 1995.

Background. The optimal approach to the investigation of mediastinal disease in patients with apparently operable non–small cell carcinoma of the lung is controversial.

Methods. We conducted a randomized, controlled trial in thoracic surgery services at mainly academic tertiary and secondary care general hospitals. We recruited 685 patients with apparently operable, suspected or proven, non–small cell carcinoma of the lung who underwent either mediastinoscopy or computed tomography. Depending on the apparent presence or absence of mediastinal nodes of greater than 1 cm, patients undergoing computed tomography either underwent mediastinoscopy or went directly to thoracotomy. The primary outcome was thoracotomy without cure, defined as resection with recurrence. Secondary outcomes included thoracotomies undertaken in patients with benign disease and costs of the two strategies.

Results. The relative risk of thoracotomy without cure in patients in the computed tomography group was 0.95 (95% confidence interval, 0.75 to 1.19). The relative risk of thoracotomy without cure or thoracotomy in patients with benign disease was 0.88 (95% confidence interval, 0.71 to 1.10). The mediastinoscopy strategy cost $708 more per patient (95% confidence interval, -$723 to $2,140).

Conclusions. The computed tomography strategy is likely to produce the same number of or fewer unnecessary thoracotomies in comparison with doing mediastinoscopy on all patients, and is also likely to be as or less expensive.




This article has been cited by other articles:


Home page
JBJSHome page
the Study to Prospectively Evaluate Reamed Intrame
Randomized Trial of Reamed and Unreamed Intramedullary Nailing of Tibial Shaft Fractures
J. Bone Joint Surg. Am., December 1, 2008; 90(12): 2567 - 2578.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
C. A. Kutlu and G. Olgac
How does definition of 'complete resection' conduct surgical management of non-small cell lung cancer?
Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 643 - 645.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. F. Meyers, F. Haddad, B. A. Siegel, J. B. Zoole, R. J. Battafarano, N. Veeramachaneni, J. D. Cooper, and G. A. Patterson
Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer
J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 822 - 829.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. Iwasaki, T. Shirakusa, S. Enatsu, S. Maekawa, Y. Yoshinaga, S. Yoneda, and S. Hoshino
Is T2 non-small cell lung cancer located in left lower lobe appropriate to upstage?
Interactive CardioVascular and Thoracic Surgery, April 1, 2005; 4(2): 126 - 129.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
C. C. Earle
Outcomes Research in Lung Cancer
J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 56 - 77.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C.S. Pramesh, R. C. Mistry, R. K. Deshpande, and S. Sharma
Is routine preoperative mediastinoscopy indicated in clinical stage I non-small-cell lung cancer?
Ann. Thorac. Surg., May 1, 2004; 77(5): 1877 - 1878.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J.E. Pilling, D.J. Stewart, A.E. Martin-Ucar, S. Muller, K.J. O'Byrne, and D.A. Waller
The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma
Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 497 - 501.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. T. Rocha, M. McCormack, G. Montana, and G. Schreiber
Association Between Lower Lobe Location and Upstaging for Early-Stage Non-small Cell Lung Cancer
Chest, April 1, 2004; 125(4): 1424 - 1430.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. Toker, Y. Bayrak, S. Tanju, S. Ziyade, O. Eroglu, D. Yilmazbayhan, S. Dilege, and G. Kalayci
Invasive staging of superior mediastinum in non-small cell lung cancer patients with specific indications
Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 472 - 476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. P. Massion and D. P. Carbone
From Clinical and Pathologic to Molecular Staging of Lung Cancer
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1587 - 1588.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Cetinkaya, A. Turna, P. Yildiz, R. Dodurgali, M. A. Bedirhan, A. Gurses, and V. Yilmaz
Comparison of clinical and surgical-pathologic staging of the patients with non-small cell lung carcinoma
Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 1000 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N. Hollings and P. Shaw
Diagnostic imaging of lung cancer
Eur. Respir. J., April 1, 2002; 19(4): 722 - 742.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. F. Esnaola, S. N. Lazarides, S. J. Mentzer, and K. M. Kuntz
Outcomes and Cost-Effectiveness of Alternative Staging Strategies for Non-Small-Cell Lung Cancer
J. Clin. Oncol., January 1, 2002; 20(1): 263 - 273.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer
Ann. Thorac. Surg., February 1, 2001; 71(2): 425 - 433.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britai, and Ireland Working Party
Guidelines on the selection of patients with lung cancer for surgery
Thorax, February 1, 2001; 56(2): 89 - 108.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
F. Tanaka, K. Yanagihara, Y. Otake, M. Li, R. Miyahara, H. Wada, and H. Ito
Biological features and preoperative evaluation of mediastinal nodal status in non-small cell lung cancer
Ann. Thorac. Surg., December 1, 2000; 70(6): 1832 - 1838.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. P. Ko, E. A. Drucker, J.-A. O. Shepard, C. F. Mountain, C. Dresler, B. Sabloff, and T. C. McLoud
CT Depiction of Regional Nodal Stations for Lung Cancer Staging
Am. J. Roentgenol., March 1, 2000; 174(3): 775 - 782.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. J Lewis
Is radical lymphadenectomy a valid oncologic procedure?
Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S11 - S12.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. A.B. Saunders, J. E. Dussek, M. J. O'Doherty, and M. N. Maisey
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer
Ann. Thorac. Surg., March 1, 1999; 67(3): 790 - 797.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
C. Laroche, F. Wells, R. Coulden, S. Stewart, M. Goddard, E. Lowry, A. Price, and D. Gilligan
Improving surgical resection rate in lung cancer
Thorax, June 1, 1998; 53(6): 445 - 449.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
Y. Lacasse, H. C. Bucher, E. Wong, L. Griffith, S. Walter, R. J. Ginsberg, and G. H. Guyatt MD,
"Incomplete Resection" in Non-Small Cell Lung Cancer: Need for a New Definition
Ann. Thorac. Surg., January 1, 1998; 65(1): 220 - 226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Pretreatment Evaluation of Non-Small-cell Lung Cancer
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 320 - 332.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
T. J. Kirby
Invited Commentary
Ann. Thorac. Surg., May 1, 1997; 63(5): 1421 - 1422.
[Full Text]


Home page
The OncologistHome page
J. Olak and A. Ng
Diagnosis and Treatment of Early-Stage Non-Small Cell Lung Cancer
Oncologist, August 1, 1996; 1(4): 201 - 209.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.